Constitutive and antibody-induced internalization of prostate-specific membrane antigen

Cancer Research

Volumn 58, Issue 18, 1998, Pages 4055-4060

  Liu, He ^a   Rajasekaran, Ayyoppan K ^a,c   Moy, Peggy ^a,b   Xia, Yan ^a   Kim, Sae ^a   Navarro, Vincent ^a   Rahmati, Rahmatullah ^a   Bander, Neil H ^a,b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN BINDING; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; IMMUNOELECTRON MICROSCOPY; INTERNALIZATION; PRIORITY JOURNAL; PROSTATE;

ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; CARCINOMA; ENDOSOMES; HUMANS; MALE; MICROSCOPY, CONFOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032530135     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Zhang, S., Zhang, H. S., Reuter, V. E., Slovin, S. F., Scher, H. I., and Livingston, P. O. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin. Cancer Res., 4: 295-302, 1998.
2. Lopes, D., Davis, W. L., Rosenstraus, M. J., Uveges, A. J., and Gilman, S. C. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res., 50: 6423-6429, 1990.
3. Israeli, R. S., Powell, C. T., Corr, J. G., Fair, W. R., and Heston, W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.
4. Wright, G. L., Jr., Haley, C., Beckett, M. L., and Schellhammer, P. F. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol. Oncol., 1: 18-28, 1995.
5. Troyer, J. K., Beckett, M. L., and Wright, G. L., Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int. J. Cancer, 62: 552-558, 1995.
6. Wright, G. L., Jr., Grob, B. M., Haley, C., Grossman, K., Newhall, K., and Moriarty, R. Up-regulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology, 48: 326-334, 1996.
7. Silver, D. A., Pellicer, I., Fair, W. R., Heston, W. D. W., and Cordon-Cardo, C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res., 3: 81-85, 1997.
8. Sokoloff, R. L., Norton, K. C., Gasior, C. L., Marker, K. M., and Grauer, L. S. Quantification of prostate specific membrane antigen (PSMA) in human tissues and subcellular fractions. Proc. Am. Assoc. Cancer Res., 39: 265, 1998.
9. Israeli, R. S., Powell, C. T., Fair, W. R., and Heston, W. D. W. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227-230, 1993.
10. Rinker-Schaeffer, C. W., Hawkins, A. L., Su, S. L., Israeli, R. S., Griffin, C. A., Isaacs, J. T., and Heston, W. D. W. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics, 30: 105-108, 1995.
11. Liu, H., Moy, P., Kim, S., Xia, Y., Rajasekaran, A., Navarro, V., Knudson, B., and Bander, N. H. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor endothelium. Cancer Res., 57: 3629-3634, 1997.
12. Carter, R. E., Feldman, A. R., and Coyle, J. T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. USA, 93: 749-753, 1996.
13. Pinto, J. T., Suffoletto, B. P., Berzin, T. M., Qiao, C. H., Lin, S., Tong, W. P., May, F., Mukherjee, B., and Heston, W. D. W. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin. Cancer Res., 2: 1445-1451, 1996.
14. Horoszewicz, J. S., Kawinski, E., and Murphy G. P. Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostatic cancer patients. Anticancer Res., 7: 927-936, 1987.
15. Troyer, J. K., Feng, Q., Beckett, M. L., and Wright, G. L., Jr. Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen. Urol. Oncol., 1: 29-37, 1995.
16. Troyer, J. K., Beckett, M. L., and Wright, G. L., Jr. Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line. Prostate, 30: 232-242, 1997.
17. Rajasekaran, A. K., Hojo, M., Huima, T., and Rodriguez-Boulon, E. Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. J. Cell Biol., 132: 451-463, 1996.
18. Bretscher, M. S., and Lutter, R. A new method for detecting endocytosed proteins. EMBO J., 7: 4087-4092, 1998.
19. Haigler, H. T., McKenna, J. A., and Cohen, S. Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J. Cell Biol., 83: 82-90, 1979.
20. Mukherjee, S., Ghosh, R. N., and Maxfield, F. R. Endocytosis. Physiol. Rev., 77: 759-803, 1997.
21. Pastan, I. H., and Willingham, M. C. Receptor-mediated endocytosis of hormones in cultured cells. Annu. Rev. Physiol., 43: 239-250, 1981.
22. Milhiet, P. C., Giocondi, M-C., Crine, P., Le Grimellec, C., Roques, B. P., and Garbay-Jaureguiberry, C. Fate of a fluorescent inhibitor of endopeptidase-24.11 using enzyme-expressing MDCK cells. Modification of its cellular processing with a monoclonal antibody. Eur. J. Cell Biol., 65: 258-268, 1994.
23. Trowbridge, I. S. Endocytosis and signals for internalization. Curr. Opin. Cell Biol., 3: 634-641, 1991.
24. Letourneur, F., and Klauser, R. D. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell, 69: 1143-1157, 1992.
25. Luthi-Carter, R., Berger, U. V., Barczak, A. K., Enna, M., and Coyle, J. T. Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc. Natl. Acad. Sci. USA, 95: 3215-3220, 1998.
26. Su, S. L., Huang, I-P., Fair, W. R., Powell, C. T., and Heston, W. D. W. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55: 1441-1443, 1995.